NCT05802511View on ClinicalTrials.gov

Study of Exablate Model 4000 Type 1.0/1.1 Following the Treatment of Neuropathic Pain

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

February 15, 2021

Study Completion Date

February 28, 2021

Conditions
Peripheral NeuropathyNeuropathic Pain
Interventions
DEVICE

Exablate treatment

Exablate treatment for Neuropathic Pain

Trial Locations (1)

98124

"IRCCS Centro Neurolesi Bonino-Pulejo", Messina

All Listed Sponsors
lead

IRCCS Centro Neurolesi Bonino Pulejo

OTHER

NCT05802511 - Study of Exablate Model 4000 Type 1.0/1.1 Following the Treatment of Neuropathic Pain | Biotech Hunter | Biotech Hunter